ArticleCancers2026
Integrating Lifestyle, Mechanistic Therapeutics, and Computational Approaches in Cancer: Highlights from the Irish Association for Cancer Research Annual Conference 2025.
Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Irish Association for Cancer Research (IACR) Annual Conference 2025, held in Belfast, showcased cutting-edge developments across the cancer research landscape. This report summarizes key presentations, highlighting innovations in drug delivery, exercise interventions, artificial intelligence and computational biology, cancer stem cell plasticity, and translational research approaches. The meeting emphasised mechanistically informed strategies, multi-modal therapies, and the integration of patient-relevant models to improve therapeutic outcomes. The sessions collectively underscored the importance of combining biological, chemical, and physical approaches, as well as emerging tools in precision oncology, to address therapeutic resistance and enhance patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.